ZA200203876B - Phosphorylation of terminal primary alcohol groups. - Google Patents

Phosphorylation of terminal primary alcohol groups.

Info

Publication number
ZA200203876B
ZA200203876B ZA200203876A ZA200203876A ZA200203876B ZA 200203876 B ZA200203876 B ZA 200203876B ZA 200203876 A ZA200203876 A ZA 200203876A ZA 200203876 A ZA200203876 A ZA 200203876A ZA 200203876 B ZA200203876 B ZA 200203876B
Authority
ZA
South Africa
Prior art keywords
phosphorylation
primary alcohol
alcohol groups
terminal primary
terminal
Prior art date
Application number
ZA200203876A
Other languages
English (en)
Inventor
Michael Barry Gravestock
Kenneth Edwin Herbert Warren
David Simon Ennis
Angela Charlotte Currie
Debra Ainge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200203876B publication Critical patent/ZA200203876B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200203876A 1999-12-03 2002-05-15 Phosphorylation of terminal primary alcohol groups. ZA200203876B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates

Publications (1)

Publication Number Publication Date
ZA200203876B true ZA200203876B (en) 2003-08-15

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203876A ZA200203876B (en) 1999-12-03 2002-05-15 Phosphorylation of terminal primary alcohol groups.

Country Status (22)

Country Link
EP (1) EP1237895A2 (no)
JP (1) JP2003515539A (no)
KR (1) KR20020058072A (no)
CN (1) CN1433421A (no)
AR (1) AR026700A1 (no)
AU (1) AU762241B2 (no)
BG (1) BG106728A (no)
BR (1) BR0016087A (no)
CA (1) CA2395052A1 (no)
CO (1) CO5271712A1 (no)
CZ (1) CZ20021912A3 (no)
EE (1) EE200200282A (no)
GB (1) GB9928499D0 (no)
HU (1) HUP0204052A2 (no)
IL (1) IL149641A0 (no)
IS (1) IS6401A (no)
MX (1) MXPA02005396A (no)
NO (1) NO20022605L (no)
PL (1) PL364762A1 (no)
SK (1) SK7862002A3 (no)
WO (1) WO2001040236A2 (no)
ZA (1) ZA200203876B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
CN1639136A (zh) 2001-09-11 2005-07-13 阿斯特拉曾尼卡有限公司 作为抗菌剂的噁唑烷酮和/或异噁唑啉
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
BR0308056A (pt) 2002-02-28 2004-12-07 Astrazeneca Ab Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto
KR20040086465A (ko) 2002-02-28 2004-10-08 아스트라제네카 아베 화합물
EP1539745B1 (en) 2002-08-12 2006-03-29 Pharmacia & Upjohn Company LLC N-aryl-2-oxazolidinones and their derivatives
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7141570B2 (en) 2002-11-21 2006-11-28 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
PL1656370T3 (pl) 2003-06-03 2013-03-29 Melinta Subsidiary Corp Biarylowe związki heterocykliczne oraz sposoby ich wytwarzania i stosowania
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
TW200526649A (en) 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
KR20130095850A (ko) 2006-09-25 2013-08-28 욱크하르트 리미티드 치환된 피페리디노페닐 옥사졸리디논
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140084A0 (en) * 1998-06-05 2002-02-10 Astra Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IS6401A (is) 2002-05-28
CN1433421A (zh) 2003-07-30
PL364762A1 (en) 2004-12-13
KR20020058072A (ko) 2002-07-12
WO2001040236A2 (en) 2001-06-07
BG106728A (en) 2003-02-28
MXPA02005396A (es) 2002-11-29
AU1715601A (en) 2001-06-12
NO20022605D0 (no) 2002-05-31
GB9928499D0 (en) 2000-02-02
BR0016087A (pt) 2002-08-06
NO20022605L (no) 2002-06-26
HUP0204052A2 (hu) 2003-03-28
EP1237895A2 (en) 2002-09-11
JP2003515539A (ja) 2003-05-07
CA2395052A1 (en) 2001-06-07
AU762241B2 (en) 2003-06-19
WO2001040236A3 (en) 2002-05-10
AR026700A1 (es) 2003-02-26
EE200200282A (et) 2003-06-16
IL149641A0 (en) 2002-11-10
SK7862002A3 (en) 2003-02-04
CZ20021912A3 (cs) 2002-08-14
CO5271712A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
ZA200203876B (en) Phosphorylation of terminal primary alcohol groups.
AU4355500A (en) Determining the physical structure of subscriber lines
HK1049966A1 (en) Dispersion formulations containing lipase inhibitors.
HK1039535A1 (en) Terminal connector
AU4175200A (en) Assignment
AU6181000A (en) Novel genes encoding protein kinase/protein phosphatase
AU6180900A (en) Novel genes encoding protein kinase/protein phosphatase
AU7460800A (en) Grounding terminal
TW481369U (en) Terminal connector
HK1038989B (zh) 端子接頭
AU7908800A (en) Urethane-group containing insulating coating
AU6355700A (en) Dsp-11 dual-specificity map kinase phosphatase
AU2001262823A1 (en) System protection scheme
GB0128847D0 (en) Monolithic capacitor array & electrical connector
EP1329501A4 (en) NEW PLA1
GB0010589D0 (en) Connector terminal
AU4683200A (en) Dsp-5 dual-specificity map kinase phosphatase
AU1283801A (en) Neurological plug
AU2000279108A1 (en) Opimization of service access
AU4213100A (en) Dsp-4 dual-specificity map kinase phosphatase
AU4206700A (en) Dsp-3 dual-specificity phosphatase
AU2569200A (en) High isolation couplers
AU4470200A (en) Dsp-8 dual-specificity map kinase phosphatase
AU4020000A (en) Dsp-2 dual-specificity map kinase phosphatase
AU2001243380A1 (en) Anonymous id